Disclosures: Dr. Hall has disclosed that he has no financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors. Dr. Peppercorn has disclosed that he receives consulting fees from Athenex and Abbott Labs, and that his spouse is employed by GlaxoSmithKline.
Correspondence: Daniel L. Hall, PhD, Harvard Medical School, 100 Cambridge Street, 16th floor, Boston, MA 02114. Email: firstname.lastname@example.org
HarroldEC, IdrisF, KeeganNM, . Prevalence of insomnia in an oncology patient population: an Irish tertiary referral center experience. J Natl Compr Canc Netw 2020;18:1623–1630.10.6004/jnccn.2020.7611)| false
QaseemA, KansagaraD, ForcieaMA, . Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125–133.2713644910.7326/M15-2175)| false
JohnsonJA, RashJA, CampbellTS, et al.. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev2016;27:20–28.
JohnsonJA, RashJA, CampbellTS, . A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 2016;27:20–28.10.1016/j.smrv.2015.07.00126434673)| false
MehrotraA, HuskampHA, SouzaJ, . Rapid growth in mental health telemedicine use among rural Medicare beneficiaries, wide variation across states. Health Aff (Millwood) 2017;36:909–917.2846135910.1377/hlthaff.2016.1461)| false
GarlandSN, XieSX, DuHamelK, . Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: a randomized clinical trial. J Natl Cancer Inst 2019;111:1323–1331.3108189910.1093/jnci/djz050)| false